TCDB is operated by the Saier Lab Bioinformatics Group

2.A.22 The Neurotransmitter:Sodium Symporter (NSS) Family

Members of the NSS family (SLC59) catalyze uptake of a variety of neurotransmitters, amino acids, osmolytes and related nitrogenous substances by a solute:Na+ symport mechanism (Rudnick et al. 2013). Sometimes Cl- is cotransported, and some exhibit a K+ dependency. The human dopamine transporter probably co-transports the positively charged or zwitterionic dopamine species with 2Na+ and 1Cl-. The human betaine/GABA transporter cotransports 3Na+ and 1 or 2Cl- with one molecule of betaine or GABA. Two different glycine transporters, GlyT1 (TC #2.A.22.2.2) and GlyT2 (TC #2.A.22.2.6), cotransport glycine with 2Na+ and 3Na+, respectively as well as 1Cl-. Most characterized members are from animals, but bacterial and archaeal homologues have been sequenced, and one bacterial homologue, TnaT of Symbiobacterium thermophilum, TC #2.A.22.5.2, has been shown to be a Na+-dependent tryptophan uptake permease with high affinity (145 nM) (Androutsellis-Theotokis et al., 2003) while a second is a tyrosine-specific Na+ symporter. Eukaryotic NSS proteins are generally of 600-800 amino acyl residues in length and possess 12 putative transmembrane helical spanners, but about 70% of prokaryotic homologues have 11 TMSs (Quick et al., 2006).  Several NSS family members have been characterized from marine invertebrates (Kinjo et al. 2013). Paudel et al. 2021 determined the effect of 24 different synthetic 4-benzylpiperidine carboxamides on the reuptake of serotonin, norepinephrine, and dopamine (DA). They identified (1) critical structural features contributing to the selectivity of a molecule for each of the monoamine transporters, (2) critical residues on the compounds that bound to the transporters, and (3) the functional role of a DA reuptake inhibitor in regulating D2R function. 1, 5-disubstituted tetrazoles are also monoamine neurotransmitter reuptake inhibitors (Paudel et al. 2021).

 Neurotransmitter: sodium symporters (NSS) have a critical role in regulating neurotransmission and are targets for psychostimulants, anti-depressants and other drugs. In eukaryotic NSS, chloride is transported together with the neurotransmitter. However, transport by the bacterial homologues LeuT, Tyt1 and TnaT is chloride independent. The crystal structure of LeuT reveals an occluded binding pocket containing leucine and two sodium ions. Zomot et al, (2007) found that introduction of a negatively charged amino acid at or near one of the two putative sodium-binding sites of the GABA (γ-aminobutyric acid) transporter GAT-1 from rat brain (also called SLC6A1) renders both net flux and exchange of GABA largely chloride independent. In contrast to wild-type GAT-1, a marked stimulation of the rate of net flux (but not of exchange) was observed when the internal pH was lowered. Equivalent mutations introduced in the mouse GABA transporter GAT4 (SLC6A11) and the human dopamine transporter DAT (SLC6A3) similarly resulted in chloride-independent transport. The reciprocal mutations in LeuT and Tyt1 rendered substrate binding and/or uptake by these bacterial NSS chloride dependent. Their data indicated that the negative charge, provided either by chloride or by the transporter itself, is required during binding and translocation of the neurotransmitter, probably to counterbalance the charge of the co-transported sodium ions.

Evidence supports the conclusion that some members of the NSS family are dimers while others are monomers, and still others can be oligomeric depending on their localization. Thus, the glycine transporter is monomeric in the plasma membrane but oligomeric when intracellular. Both the serotonin and dopamine transporters may be dimeric. In the latter case, the extracellular end of TMS6 may be at a symmetrical dimer interface (Hastrup et al., 2001).  In mammals, several isoforms of these transporters (e.g., DAT and NET) can be generated by tissue-specific alternative splicing (Sogawa et al. 2010).  Shared dynamics of LeuT superfamily members and allosteric differentiation by structural irregularities and multimerization have been analyzed and reviewed (Ponzoni et al. 2018).  A conserved intramolecular ion-pair plays a critical but divergent role in regulation of dimerization and transport function among the monoamine transporters (SERT, DAT, and NAT (Chen et al. 2024). Structural bioinformatic studies of serotonin, dopamine and norepinephrine transporters has revealed the basis for their natural mutations (Karagöl et al. 2024).

Tavoulari et al. (2011) described conversion of the Cl- -independent prokaryotic tryptophan transporter TnaT (2.A.22.4.1) to a fully functional Cl- -dependent form by a single point mutation, D268S. Mutations in TnaT-D268S, in wild type TnaT and in a serotonin transporter (SERT; 2.A.22.1.1) provided direct evidence for the involvement of each of the proposed residues in Cl- coordination. In both SERT and TnaT-D268S, Cl- and Na+ mutually increase each other's potency, consistent with am electrostatic interaction through adjacent binding sites.  Rigid bodies and relative movements of TMSs occur during distinct steps of the transport cycle (Licht et al. 2024). In all transporters with the LeuT fold, the bundle (first two TMSs of each repeat) rotates relative to the hash (third and fourth TMSs). Motions of the arms (fifth TMS) to close or open the intracellular and outer vestibules are common, as is a TMS1a swing, with notable variations in the opening-closing motions of the outer vestibule. These analyses suggest that LeuT-fold transporters layer distinct motions on a common bundle-hash rock and demonstrate that systematic analyses can provide new insights into large structural datasets (Licht et al. 2024).

Several members of the NSS family have been shown to exhibit channel-like properties under certain experimental conditions. Thus, sizable unitary ionic currents have been reported for membrane patches containing either the γ-aminobutyrate, norepinephrine or serotonin transporter. In the presence of Zn2+ (10 μM), the dopamine transporter (DAT) catalyzes uncoupled Cl- conductance (Meinild et al., 2004). Channel-like currents have also been measured for mammalian Na+/H+/K+-coupled glutamate transporters of the DAACS family (TC #2.A.23). Evidence shows that these channels can accommodate neurotransmitters as well as inorganic ions. One of these, CAATCH1 (TC #2.A.22.2.4) can function as an amino acid-gated cation (K+ and Na+) channel (Quick and Stevens, 2001). Different amino acids (pro, thr, met) differentially affect the state probability of the channel. These observations suggest that, as has been demonstrated for carriers of a few other families, neurotransmitter transporters can be induced to function as voltage-gated channels.

The GABA transporter, GAT-1 (TC #2.A.23.3.2), can catalyze channel-like fluxes of Li+ and K+. Mutations in TMS1 can lock the permease in the 'cation leak' mode (Kanner, 2003). The leak in the G63C (but not the G63S) mutant could be blocked by addition of membrane impermeable sulfhydryl reagents, suggesting that this position is accessible from the external aqueous medium. Thus, TMS1 contains determinants of both Na+-coupled GABA transport and the cation leak.

Cocaine and related drugs act by inhibiting clearance of released monoamine neurotransmitters from the synaptic cleft. Cocaine inhibits uptake of serotonin via SERT, dopamine via DAT, and norepinephrine via NET. Cocaine binds with high affinity to all three transporters, exhibiting competitive inhibition with the monoamine substrates, probably by binding to the active sites (Rasmussen et al., 2001). Dual inhibition of serotonin and norepinephrine transporters (hSERT and hNET) (serotonin-norepinephrine reuptake inhibitors, SNRIs) gives greatly improved efficacy and tolerability for treating major depressive disorder (MDD) compared with selective reuptake inhibitors (Xue et al. 2018).

The differential expression patterns and physiological roles of the glycine transporter subtypes have been exploited in the development of novel transport inhibitors to treat schizophrenia (GLYT1 inhibitors). GLYT1 transports glycine and also the N-methyl derivative of glycine, sarcosine, whereas GLYT2 only transports glycine. Glycine is an inhibitory neurotransmitter in the spinal cord and brain stem, where it acts on strychnine-sensitive glycine receptors, and is also an excitatory neurotransmitter throughout the brain and spinal cord, where it acts as a coagonist with L-glutamate on the N-methyl-D-aspartate subtypes of glutamate receptors. Glycine transporters regulate glycine concentrations within both inhibitory and excitatory synapses. The GLYT1 subtypes of glycine transporters are expressed in glial cells surrounding both excitatory and inhibitory synapses, whereas the GLYT2 subtypes of glycine transporters are expressed in presynaptic inhibitory glycinergic neurons (Vandenberg et al. 2007).

There are two Na+/Cl- -dependent glycine transporters, GLYT1 and GLYT2, which control extracellular glycine concentrations, and these transporters show differences in substrate selectivity and blocker sensitivity. Differences in substrate selectivity can be attributed to a single difference of a glycine residue in transmembrane domain 6 of GLYT1 for a serine residue at the corresponding position of GLYT2 (Vandenberg et al., 2007).

The crystal structure of a bacterial member of the NSS family has been determined complexed to leucine and 2 Na+ (Yamashita et al., 2005). The protein core consists of the first ten of the 12 TMSs with segments 1-5 and 6-10 exhibiting a pseudo-2-fold axis in the plane of the membrane. Leucine and the sodium ions are bound within the protein core, halfway across the membrane bilayer, in an occluded site devoid of water. The leucine and ion binding sites are defined by partially unwound transmembrane helices, with main-chain atoms and helix dipoles having key roles in substrate and ion binding. The binding pocket of LeuT contains two metal binding sites (Caplan et al., 2008). The first ion in site NA1 is directly coupled to the bound substrte (Leu) with the second ion in the neighboring site (NA2) only approximately 7 A away. Double ion occupancy of the binding pocket is required to ensure substrate coupling to Na+ (but not to Li+ or K+ cations). The presence of the ion in site NA2 is required for structural stability of the binding pocket as well as amplified selectivity for Na+ in the case of double ion occupancy (Caplan et al., 2008).

Substrate binding from the extracellular side of LeuT facilitates intracellular gate opening and substrate release at the intracellular face of the protein (Zhao et al., 2011). In the presence of alanine, a substrate that is transported ∼10-fold faster than leucine, alanine-induced dynamics are induced in the intracellular gate region of LeuT that directly correlate with transport efficiency. Thus, binding of a second substrate (S2) in the extracellular vestibule appears to act cooperatively with the primary substrate (S1) to control intracellular gating more than 30 Å away.

In the presence of Na+, the leucine-bound state of the invertebrate neutral amino acid transporter, KAAT1 of Manduca sexta (TC#2.A.22.2.5) is supposed to be relatively stable, while in the presence of K+, and at negative potentials, the progression of the leucine-bound form along the cycle is favoured. In this context, serine 308 appears to be important in allowing the change to the inward-facing conformation of the transporter following substrate binding, rather than in determining the binding specificity (Miszner et al., 2007). This lepidopteran neutral amino acid transporter has an unusual cation selectivity, being activated by K+ and Li+ in addition to Na+. Asp338 is essential for KAAT1 activation by K+ and for the coupling of amino acid transport to ion fluxes. Lys102 is likely to interact with Asp338 (Castagna et al., 2007). Asp338 corresponds to Asn286, a residue located in the Na+ binding site in the crystal structure of the NSS transporter LeuT. Lys102, interacting with Asp338, could contribute to the spatial organization of the KAAT1 cation binding site and the permeation pathway.

Transporters of the NSS family, or SLC6 family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. These transporters assume various quaternary arrangements ranging from monomers to complex stoichiometries with multiple subunits (Jayaraman et al. 2020). Dopamine and serotonin transporter oligomerization has been implicated in trafficking of newly formed proteins from the endoplasmic reticulum to the plasma membrane with a pre-fixed assembly. Once at the plasma membrane, oligomers are kept fixed in their quaternary assembly by interaction with phosphoinositides. It has been shown that oligomerization supports the activity of release-type psychostimulants. Single molecule microscopy revealed that the stoichiometry differs between individual members of the SLC6 family (Jayaraman et al. 2020). Moreover, handling of intracellular K+ determines the voltage dependence of plasmalemmal monoamine transporter function. Thus, DAT and NET differ from SERT in intracellular handling of K+. In DAT and NET, substrate uptake is voltage-dependent due to the transient nature of intracellular K+ binding, which precluded K+ antiport. SERT, however, antiports K+ and achieves voltage-independent transport (Bhat et al. 2021).

The generalized transport reaction for the members of this family is:

solute (out) + Na+ (out) → solute (in) + Na+ (in)

This family belongs to the: APC Superfamily.

References associated with 2.A.22 family:

Abe, H., T. Sugasaki, M. Kanehara, T. Shimada, S.J. Gomi, F. Ohbayashi, and T. Oshiki. (2000). Identification and genetic mapping of RAPD markers linked to the densonucleosis refractoriness gene, nsd-2, in the silkworm, Bombyx mori. Genes Genet Syst 75: 93-96. 10925787
Andersen, J., N. Stuhr-Hansen, L. Zachariassen, S. Toubro, S.M. Hansen, J.N. Eildal, A.D. Bond, K.P. Bøgesø, B. Bang-Andersen, A.S. Kristensen, and K. Strømgaard. (2011). Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters. Proc. Natl. Acad. Sci. USA 108: 12137-12142. 21730142
Anderson, C.M., A. Howard, J.R. Walters, V. Ganapathy, and D.T. Thwaites. (2009). Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+- and Cl--dependent TauT (SLC6A6). J. Physiol. 587: 731-744. 19074966
Anderson, C.M.H., N. Edwards, A.K. Watson, M. Althaus, and D.T. Thwaites. (2022). Reshaping the Binding Pocket of the Neurotransmitter:Solute Symporter (NSS) Family Transporter SLC6A14 (ATB0,+) Selectively Reduces Access for Cationic Amino Acids and Derivatives. Biomolecules 12:. 36291613
Androutsellis-Theotokis, A., N.R. Goldberg, K. Ueda, T. Beppu, M.L. Beckman, S. Das, J.A. Javitch, and G. Rudnick. (2003). Characterization of a functional bacterial homologue of sodium-dependent neurotransmitter transporters. J. Biol. Chem. 278: 12703-12709. 12569103
Ansar, M., E. Ranza, M. Shetty, S.A. Paracha, M. Azam, I. Kern, J. Iwaszkiewicz, O. Farooq, C.J. Pournaras, A. Malcles, M. Kecik, C. Rivolta, W. Muzaffar, A. Qurban, L. Ali, Y. Aggoun, F.A. Santoni, P. Makrythanasis, J. Ahmed, R. Qamar, M.T. Sarwar, L.K. Henry, and S.E. Antonarakis. (2019). Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency. Hum Mol Genet. [Epub: Ahead of Print] 31903486
Arribas-González, E., P. Alonso-Torres, C. Aragón, and B. López-Corcuera. (2013). Calnexin-Assisted Biogenesis of the Glycine Transporter 2 (GlyT2). PLoS One 8: e63230. 23650557
Aubrey, K.R., F.M. Rossi, R. Ruivo, S. Alboni, G.C. Bellenchi, A. Le Goff, B. Gasnier, and S. Supplisson. (2007). The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype. J. Neurosci. 27: 6273-6281. 17554001
Augier, E., E. Barbier, R.S. Dulman, V. Licheri, G. Augier, E. Domi, R. Barchiesi, S. Farris, D. Nätt, R.D. Mayfield, L. Adermark, and M. Heilig. (2018). A molecular mechanism for choosing alcohol over an alternative reward. Science 360: 1321-1326. 29930131
Banović, M., T. Bordukalo-Niksić, M. Balija, L. Cicin-Sain, and B. Jernej. (2010). Platelet serotonin transporter (5HTt): physiological influences on kinetic characteristics in a large human population. Platelets 21: 429-438. 20528260
Barilli, A., R. Visigalli, F. Ferrari, G. Borsani, V. Dall''Asta, and B.M. Rotoli. (2021). Flagellin From Stimulates ATB Transporter for Arginine and Neutral Amino Acids in Human Airway Epithelial Cells. Front Immunol 12: 641563. 33841424
Bartolomé-Martín, D., I. Ibáñez, D. Piniella, E. Martínez-Blanco, S.G. Pelaz, and F. Zafra. (2019). Identification of potassium channel proteins Kv7.2/7.3 as common partners of the dopamine and glutamate transporters DAT and GLT-1. Neuropharmacology. [Epub: Ahead of Print] 30885609
Beckman, M.L. and M.W. Quick. (1998). Neurotransmitter transporter: regulators of function and functional regulation. J. Membr. Biol. 164: 1-10. 9636239
Ben-Yona A. and Kanner BI. (2012). An Acidic Amino Acid Transmembrane Helix 10 Residue Conserved in the Neurotransmitter:Sodium:Symporters Is Essential for the Formation of the Extracellular Gate of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1. J Biol Chem. 287(10):7159-68. 22235131
Ben-Yona, A., A. Bendahan, and B.I. Kanner. (2011). A glutamine residue conserved in the neurotransmitter:sodium:symporters is essential for the interaction of chloride with the GABA transporter GAT-1. J. Biol. Chem. 286: 2826-2833. 21098479
Benito-Muñoz, C., A. Perona, R. Felipe, G. Pérez-Siles, E. Núñez, C. Aragón, and B. López-Corcuera. (2021). Structural Determinants of the Glycine Transporter 2 for the Selective Inhibitors ALX1393 and ORG25543. ACS Chem Neurosci 12: 1860-1872. 34003005
Berfield, J.L., L.C. Wang, and M.E.A. Reith. (1999). Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species? J. Biol. Chem. 274: 4876-4882. 9988729
Bertram S., Cherubino F., Bossi E., Castagna M. and Peres A. (2011). GABA reverse transport by the neuronal cotransporter GAT1: influence of internal chloride depletion. Am J Physiol Cell Physiol. 301(5):C1064-73. 21775701
Bhat, S., M. Niello, K. Schicker, C. Pifl, H.H. Sitte, M. Freissmuth, and W. Sandtner. (2021). Handling of intracellular K determines voltage dependence of plasmalemmal monoamine transporter function. Elife 10:. 34061030
Billesbolle CB., Kruger MB., Shi L., Quick M., Li Z., Stolzenberg S., Kniazeff J., Gotfryd K., Mortensen JS., Javitch JA., Weinstein H., Loland CJ. and Gether U. (2015). Substrate-induced Unlocking of the Inner Gate Determines the Catalytic Efficiency of a Neurotransmitter:Sodium Symporter. J Biol Chem. 290(44):26725-38. 26363074
Borden, L.A., K.E. Smith, P.R. Hartig, T.A. Branchek, and R.L. Weinshank. (1992). Molecular heterogeneity of the γ-aminobutyric acid (GABA) transport system. J. Biol. Chem. 267: 21098-21104. 1400419
Boudko, D.Y., A.B. Kohn, E.A. Meleshkevitch, M.K. Dasher, T.J. Seron, B.R. Stevens, and W.R. Harvey. (2005). Ancestry and progeny of nutrient amino acid transporters. Proc. Natl. Acad. Sci. USA 102: 1360-1365. 15665107
Bröer, S. (2008). Amino acid transport across mammalian intestinal and renal epithelia. Physiol. Rev. 88: 249-286. 18195088
Broer A., K. Klingel, S. Kowalczuk, J.E. Rasko, J. Cavanaugh, S. Broer. (2004). Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder. J. Biol. Chem. 279: 24467-24476. 15044460
Bröer, A., S. Balkrishna, G. Kottra, S. Davis, A. Oakley, and S. Bröer. (2009). Sodium translocation by the iminoglycinuria associated imino transporter (SLC6A20). Mol. Membr. Biol. 26: 333-346. 19657969
Cai, G., P.S. Salonikidis, J. Fei, W. Schwarz, R. Schülein, W. Reutter, and H. Fan. (2005). The role of N-glycosylation in the stability, trafficking and GABA-uptake of GABA-transporter 1. Terminal N-glycans facilitate efficient GABA-uptake activity of the GABA transporter. FEBS J. 272: 1625-1638. 15794750
Caltagarone J., Ma S. and Sorkin A. (2015). Dopamine transporter is enriched in filopodia and induces filopodia formation. Mol Cell Neurosci. 68:120-130. 25936602
Camargo, S.M., D. Singer, V. Makrides, K. Huggel, K.M. Pos, C.A. Wagner, K. Kuba, U. Danilczyk, F. Skovby, R. Kleta, J.M. Penninger, and F. Verrey. (2009). Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology 136: 872-882. 19185582
Camicia, F., H.R. Vaca, I. Guarnaschelli, U. Koziol, O.V. Mortensen, and A.C.K. Fontana. (2022). Molecular characterization of the serotonergic transporter from the cestode Echinococcus granulosus: pharmacology and potential role in the nervous system. Parasitol Res. [Epub: Ahead of Print] 35169884
Cao, H., X. Liu, Y. An, G. Zhou, Y. Liu, M. Xu, W. Dong, S. Wang, F. Yan, K. Jiang, and B. Wang. (2017). Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine. Sci Rep 7: 10322. 28871143
Caplan, D.A., J.O. Subbotina, and S.Y. Noskov. (2008). Molecular mechanism of ion-ion and ion-substrate coupling in the Na+-dependent leucine transporter LeuT. Biophys. J. 95: 4613-4621. 18708457
Carvelli, L., R.D. Blakely, and L.J. DeFelice. (2008). Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc. Natl. Acad. Sci. USA 105: 14192-14197. 18768815
Castagna, M., A. Soragna, S.A. Mari, M. Santacroce, S. Betté, P.G. Mandela, G. Rudnick, A. Peres, and V.F. Sacchi. (2007). Interaction between lysine 102 and aspartate 338 in the insect amino acid cotransporter KAAT1. Am. J. Physiol. Cell Physiol. 293: C1286-1295. 17626242
Castagna, M., C. Shayakul, D. Trotti, V.F. Sacchi, W.R. Harvey, and M.A. Hediger. (1998). Cloning and characterization of a potassium-coupled amino acid transporter. Proc. Natl. Acad. Sci. USA 95: 5395-5400. 9560287
Castillero, E., E. Fitzpatrick, S.J. Keeney, A.M. D''Angelo, B.B. Pressly, M.T. Simpson, M. Kurade, W.C. Erwin, V. Moreno, C. Camillo, H.J. Shukla, V.V. Inamdar, A. Aghali, J.B. Grau, E. Salvati, I. Nissim, L. Rauova, M.A. Oyama, S.J. Stachelek, C. Brown, A.M. Krieger, R.J. Levy, and G. Ferrari. (2023). Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation. Sci Transl Med 15: eadc9606. 36599005
Chan, M.C., E. Procko, and D. Shukla. (2022). Structural Rearrangement of the Serotonin Transporter Intracellular Gate Induced by Thr276 Phosphorylation. ACS Chem Neurosci 13: 933-945. 35258286
Chater, R.C., A.S. Quinn, K. Wilson, Z.J. Frangos, P. Sutton, S. Jayakumar, C.L. Cioffi, M.L. O''Mara, and R.J. Vandenberg. (2023). The efficacy of the analgesic GlyT2 inhibitor, ORG25543, is determined by two connected allosteric sites. J Neurochem. [Epub: Ahead of Print] 38131125
Chen, J.-G. and G. Rudnik. (2000). Permeation and gating residues in serotonin transporter. Proc. Natl. Acad. Sci. USA 97: 1044-1049. 10655481
Chen, N., J. Rickey, J.L. Berfield, and M.E.A. Reith. (2004). Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine binding. J. Biol. Chem. 279: 5508-5519. 14660644
Chen, S., X. Huang, X. Zhang, C. Li, and Y.W. Zhang. (2024). A Conserved Intramolecular Ion-Pair Plays a Critical but Divergent Role in Regulation of Dimerization and Transport Function among the Monoamine Transporters. Int J Mol Sci 25:. 38612840
Cheng, M.H. and I. Bahar. (2013). Coupled global and local changes direct substrate translocation by neurotransmitter-sodium symporter ortholog LeuT. Biophys. J. 105: 630-639. 23931311
Cheng, M.H. and I. Bahar. (2014). Complete Mapping of Substrate Translocation Highlights the Role of LeuT N-terminal Segment in Regulating Transport Cycle. PLoS Comput Biol 10: e1003879. 25299050
Cheng, M.H., J. Garcia-Olivares, S. Wasserman, J. DiPietro, and I. Bahar. (2017). Allosteric Modulation of Human Dopamine Transporter Activity under Conditions Promoting its Dimerization. J. Biol. Chem. [Epub: Ahead of Print] 28584050
Christiansen, B., A.K. Meinild, A.A. Jensen, and H. Braüner-Osborne. (2007). Cloning and characterization of a functional human γ-aminobutyric acid (GABA) transporter, human GAT-2. J. Biol. Chem. 282: 19331-19341. 17502375
Cioffi, C.L. (2018). Glycine transporter-1 inhibitors: a patent review (2011-2016). Expert Opin Ther Pat 28: 197-210. 29338548
Clark, J.A. and S.G. Amara. (1993). Amino acid neurotransmitter transporters: structure, function, and molecular diversity. BioEssays 15: 323-332. 8102052
Coleman, J.A., D. Yang, Z. Zhao, P.C. Wen, C. Yoshioka, E. Tajkhorshid, and E. Gouaux. (2019). Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport. Nature 569: 141-145. 31019304
Coleman, J.A., E.M. Green, and E. Gouaux. (2016). X-ray structures and mechanism of the human serotonin transporter. Nature 532: 334-339. 27049939
Danbolt, N.C., B. López-Corcuera, and Y. Zhou. (2021). Reconstitution of GABA, Glycine and Glutamate Transporters. Neurochem Res. [Epub: Ahead of Print] 33905037
Dang, C., Q. Bian, F. Wang, H. Wang, and Z. Liang. (2024). Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling. Sci Rep 14: 2116. 38267509
Danilczyk, U., R. Sarao, C. Remy, C. Benabbas, G. Stange, A. Richter, S. Arya, J.A. Pospisilik, D. Singer, S.M. Camargo, V. Makrides, T. Ramadan, F. Verrey, C.A. Wagner, and J.M. Penninger. (2006). Essential role for collectrin in renal amino acid transport. Nature 444: 1088-1091. 17167413
Dayan, O., A. Nagarajan, R. Shah, A. Ben-Yona, L.R. Forrest, and B.I. Kanner. (2017). An extra amino acid residue in transmembrane domain 10 of the GABA transporter GAT-1 is required for efficient ion-coupled transport. J. Biol. Chem. [Epub: Ahead of Print] 28213519
Demchyshyn, L.L., Z.B. Pristupa, K.S. Sugamori, E.L. Barker, R.D. Blakely, W.J. Wolfgang, M.A. Forte, and H.B. Niznik. (1994). Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 91: 5158-5162. 8197200
Deng, J., X. Zheng, L. Shang, C.G. Zhan, and F. Zheng. (2022). Gender differences in cocaine-induced hyperactivity and dopamine transporter trafficking to the plasma membrane. Addict Biol 27: e13236. 36301205
Deutschbauer, A., M.N. Price, K.M. Wetmore, W. Shao, J.K. Baumohl, Z. Xu, M. Nguyen, R. Tamse, R.W. Davis, and A.P. Arkin. (2011). Evidence-based annotation of gene function in Shewanella oneidensis MR-1 using genome-wide fitness profiling across 121 conditions. PLoS Genet 7: e1002385. 22125499
Devlin, A.M., U. Brain, J. Austin, and T.F. Oberlander. (2010). Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One 5: e12201. 20808944
Ding, X., D. Yan, X. Zhang, B. Liu, and G. Zhu. (2021). Metabolomics Analysis of the Effect of GAT-2 Deficiency on Th1 Cells in Mice. J Proteome Res 20: 5054-5063. 34647753
Donly, C., L. Verellen, W. Cladman, and S. Caveney. (2007). Functional comparison of full-length and N-terminal-truncated octopamine transporters from Lepidoptera. Insect Biochem Mol Biol 37: 933-940. 17681232
Feldman, D.H., W.R. Harvey, and B.R. Stevens. (2000). A novel electrogenic amino acid transporter is activated by K+ or Na+, is alkaline pH-dependent, and is Cl--independent. J. Biol. Chem. 275: 24518-24526. 10829035
Fenker KE., Hansen AA., Chong CA., Jud MC., Duffy BA., Norton JP., Hansen JM. and Stanfield GM. (2014). SLC6 family transporter SNF-10 is required for protease-mediated activation of sperm motility in C. elegans. Dev Biol. 393(1):171-82. 24929237
Fenollar-Ferrer, C., T. Stockner, T.C. Schwarz, A. Pal, J. Gotovina, T. Hofmaier, K. Jayaraman, S. Adhikary, O. Kudlacek, A.R. Mehdipour, S. Tavoulari, G. Rudnick, S.K. Singh, R. Konrat, H.H. Sitte, and L.R. Forrest. (2014). Structure and regulatory interactions of the cytoplasmic terminal domains of serotonin transporter. Biochemistry 53: 5444-5460. 25093911
Fjorback, A.W., S. Sundbye, J.C. Dächsel, S. Sinning, O. Wiborg, and P.H. Jensen. (2011). P25α / TPPP expression increases plasma membrane presentation of the dopamine transporter and enhances cellular sensitivity to dopamine toxicity. FEBS J. 278: 493-505. 21182589
Focht, D., C. Neumann, J. Lyons, A. Eguskiza Bilbao, R. Blunck, L. Malinauskaite, I.O. Schwarz, J.A. Javitch, M. Quick, and P. Nissen. (2020). A non-helical region in transmembrane helix 6 of hydrophobic amino acid transporter MhsT mediates substrate recognition. EMBO. J. e105164. [Epub: Ahead of Print] 33155685
Foster, J.D., J.W. Yang, A.E. Moritz, S. Challasivakanaka, M.A. Smith, M. Holy, K. Wilebski, H.H. Sitte, and R.A. Vaughan. (2012). Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux. J. Biol. Chem. 287: 29702-29712. 22722938
Frangos, Z.J., K.A. Wilson, H.M. Aitken, R. Cantwell Chater, R.J. Vandenberg, and M.L. O''Mara. (2023). Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2. Life Sci Alliance 6:. 36690444
Gabrielsen, M., A.W. Ravna, K. Kristiansen, and I. Sylte. (2012). Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations. J Mol Model 18: 1073-1085. 21670993
Galli, A., R.D. Blakely, and L.J. DeFelice. (1998) Patch-clamp and amperometric recordings from norepinephrine transporters: channels activity and voltage-dependent uptake. Proc. Natl. Acad. Sci. USA 95: 13260-13265. 9789076
García-Delgado, M., P. García-Miranda, M.J. Peral, M.L. Calonge, and A.A. Ilundáin. (2007). Ontogeny up-regulates renal Na+/Cl-/creatine transporter in rat. Biochim. Biophys. Acta. 1768: 2841-2848. 17916324
Gill, J.L., D. Capper, J.F. Vanbellinghen, S.K. Chung, R.J. Higgins, M.I. Rees, G.D. Shelton, and R.J. Harvey. (2011). Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene. Neurobiol Dis 43: 184-189. 21420493
Gimenez C., Perez-Siles G., Martinez-Villarreal J., Arribas-Gonzalez E., Jimenez E., Nunez E., de Juan-Sanz J., Fernandez-Sanchez E., Garcia-Tardon N., Ibanez I., Romanelli V., Nevado J., James VM., Topf M., Chung SK., Thomas RH., Desviat LR., Aragon C., Zafra F., Rees MI., Lapunzina P., Harvey RJ. and Lopez-Corcuera B. (2012). A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2. J Biol Chem. 287(34):28986-9002. 22753417
Goldstein, J., A. Thomas-Wilson, E. Groopman, V. Aggarwal, S. Bianconi, R. Fernandez, K. Hart, N. Longo, N. Liang, D. Reich, H. Wallis, M. Weaver, S. Young, and S. Mercimek-Andrews. (2024). ClinGen variant curation expert panel recommendations for classification of variants in GAMT, GATM and SLC6A8 for cerebral creatine deficiency syndromes. Mol Genet Metab 142: 108362. [Epub: Ahead of Print] 38452609
Gotfryd, K., T. Boesen, J.S. Mortensen, G. Khelashvili, M. Quick, D.S. Terry, J.W. Missel, M.V. LeVine, P. Gourdon, S.C. Blanchard, J.A. Javitch, H. Weinstein, C.J. Loland, P. Nissen, and U. Gether. (2020). X-ray structure of LeuT in an inward-facing occluded conformation reveals mechanism of substrate release. Nat Commun 11: 1005. 32081981
Gradisch, R., D. Szöllősi, M. Niello, E. Lazzarin, H.H. Sitte, and T. Stockner. (2022). Occlusion of the human serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain. J. Biol. Chem. 101613. [Epub: Ahead of Print] 35065961
Grouleff, J., S. Søndergaard, H. Koldsø, and B. Schiøtt. (2015). Properties of an Inward-Facing State of LeuT: Conformational Stability and Substrate Release. Biophys. J. 108: 1390-1399. 25809252
Hägglund, M.G., S.V. Hellsten, S. Bagchi, A. Ljungdahl, V.C. Nilsson, S. Winnergren, O. Stephansson, J. Rumaks, S. Svirskis, V. Klusa, H.B. Schiöth, and R. Fredriksson. (2013). Characterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system. BMC Neurosci 14: 54. 23672601
Hastrup, H., A. Karlin, and J.A. Javitch. (2001). Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment. Proc. Natl. Acad. Sci. USA 98: 10055-10060. 11526230
Hauf, K., L. Barsch, D. Bauer, R. Buchert, A. Armbruster, L. Frauenfeld, U. Grasshoff, and V. Eulenburg. (2020). GlyT1 Encephalopathy: Characterization of presumably disease causing GlyT1 mutations. Neurochem Int 104813. [Epub: Ahead of Print] 32712301
Henry, L.K., H. Iwamoto, J.R. Field, K. Kaufmann, E.S. Dawson, M.T. Jacobs, C. Adams, B. Felts, I. Zdravkovic, V. Armstrong, S. Combs, E. Solis, G. Rudnick, S.Y. Noskov, L.J. DeFelice, J. Meiler, and R.D. Blakely. (2011). A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport. J. Biol. Chem. 286: 30823-30836. 21730057
Hong, W.C. and S.G. Amara. (2010). Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J. Biol. Chem. 285: 32616-32626. 20688912
Hopkins, S.C., S. Sunkaraneni, E. Skende, J. Hing, J.A. Passarell, A. Loebel, and K.S. Koblan. (2015). Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults. Clin Drug Investig. [Epub: Ahead of Print] 26597180
Hu, J., C. Weise, C. Böttcher, H. Fan, and J. Yin. (2017). Expression, purification and structural analysis of functional GABA transporter 1 using the baculovirus expression system. Beilstein J Org Chem 13: 874-882. 28546845
Hu, Y., E.A. Ehli, J.J. Hudziak, and G.E. Davies. (2012). Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region. Pharmacogenomics J 12: 372-378. 21647174
Humińska-Lisowska, K., K. Chmielowiec, A. Strońska-Pluta, J. Chmielowiec, A. Suchanecka, J. Masiak, M. Michałowska-Sawczyn, A. Boroń, P. Cięszczyk, and A. Grzywacz. (2023). Epigenetic Analysis of the Dopamine Transporter Gene with a Focus on Personality Traits in Athletes. Int J Mol Sci 24:. 37240274
Ito, K., K. Kidokoro, H. Sezutsu, J. Nohata, K. Yamamoto, I. Kobayashi, K. Uchino, A. Kalyebi, R. Eguchi, W. Hara, T. Tamura, S. Katsuma, T. Shimada, K. Mita, and K. Kadono-Okuda. (2008). Deletion of a gene encoding an amino acid transporter in the midgut membrane causes resistance to a Bombyx parvo-like virus. Proc. Natl. Acad. Sci. USA 105: 7523-7527. 18495929
Ito, K., S. Shimura, S. Katsuma, Y. Tsuda, J. Kobayashi, H. Tabunoki, T. Yokoyama, T. Shimada, and K. Kadono-Okuda. (2016). Gene expression and localization analysis of Bombyx mori bidensovirus and its putative receptor in B. mori midgut. J Invertebr Pathol 136: 50-56. 26953258
Ito, K., T. Fujii, T. Yokoyama, and K. Kadono-Okuda. (2018). Decrease in the expression level of the gene encoding the putative Bombyx mori bidensovirus receptor during virus infection. Arch Virol 163: 3327-3338. 30220036
Jayanthi, L.D., S. Apparsundaram, M.D. Malone, E. Ward, D.M. Miller, M. Eppler, and R.D. Blakely. (1998). Mol. Pharmacol. 54: 601-609.
Jayaraman, K., A.K. Das, D. Luethi, D. Szöllősi, G.J. Schütz, M.E.A. Reith, H.H. Sitte, and T. Stockner. (2020). SLC6 transporter oligomerization. J Neurochem. [Epub: Ahead of Print] 32767560
Jayaraman, K., A.N. Morley, D. Szöllősi, T.A. Wassenaar, H.H. Sitte, and T. Stockner. (2018). Dopamine transporter oligomerization involves the scaffold domain, but spares the bundle domain. PLoS Comput Biol 14: e1006229. 29874235
Jha, P., L. Ragnarsson, and R.J. Lewis. (2020). Structure-Function of the High Affinity Substrate Binding Site (S1) of Human Norepinephrine Transporter. Front Pharmacol 11: 217. 32210813
Jiang, G., L. Zhuang, S. Miyauchi, K. Miyake, Y.-J. Fei, and V. Ganapathy. (2005). A Na+/Cl--coupled GABA transporter, GAT-1, from Caenorhabditis elegans. Structural and functional features, specific expression in GABA-ergic neurons, and involvement in muscle function. J. Biol. Chem. 280: 2065-2077. 15542610
Jomura, R., S.I. Akanuma, M. Tachikawa, and K.I. Hosoya. (2022). SLC6A and SLC16A family of transporters: Contribution to transport of creatine and creatine precursors in creatine biosynthesis and distribution. Biochim. Biophys. Acta. Biomembr 1864: 183840. 34921896
Just, H., H.H. Sitte, J.A. Schmid, M. Freissmuth, and O. Kudlacek. (2004). Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J. Biol. Chem. 279: 6650-6657. 14660642
Kahen, A., H. Kavus, A. Geltzeiler, C. Kentros, C. Taylor, E. Brooks, L. Green Snyder, and W. Chung. (2021). Neurodevelopmental phenotypes associated with pathogenic variants in. J Med Genet. [Epub: Ahead of Print] 34006619
Kanner, B.I. (2003). Transmembrane domain I of the γ-aminobutyric acid transporter GAT-1 plays a crucial role in the transition between cation leak and transport modes. J. Biol. Chem. 278: 3705-3712. 12446715
Karagöl, T., A. Karagöl, and S. Zhang. (2024). Structural bioinformatics studies of serotonin, dopamine and norepinephrine transporters and their AlphaFold2 predicted water-soluble QTY variants and uncovering the natural mutations of L->Q, I->T, F->Y and Q->L, T->I and Y->F. PLoS One 19: e0300340. 38517879
Kardos, J., A. Palló, A. Bencsura, and A. Simon. (2010). Assessing structure, function and druggability of major inhibitory neurotransmitter γ-aminobutyrate symporter subtypes. Curr. Med. Chem. 17: 2203-2213. 20423300
Kaufmann, K.W., E.S. Dawson, L.K. Henry, J.R. Field, R.D. Blakely, and J. Meiler. (2009). Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies. Proteins 74: 630-642. 18704946
Kavanaugh, M.P. (1998). Neurotransmitter transport: models in flux. Proc. Natl. Acad. Sci. USA 95: 12737-12738. 9788979
Keighron, J.D., J. Bonaventura, Y. Li, J.W. Yang, E.M. DeMarco, M. Hersey, J. Cao, W. Sandtner, M. Michaelides, H.H. Sitte, A.H. Newman, and G. Tanda. (2023). Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release. Transl Psychiatry 13: 202. 37311803
Khafizov, K., R. Staritzbichler, M. Stamm, and L.R. Forrest. (2010). A study of the evolution of inverted-topology repeats from LeuT-fold transporters using AlignMe. Biochemistry 49: 10702-10713. 21073167
Khoshbouei, H., H. Wang, J.D. Lechleiter, J.A. Javitch, and A. Galli. (2003). Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J. Biol. Chem. 278: 12070-12077. 12556446
Kilic, F. and G. Rudnick. (2000). Oligomerization of serotonin transporter and its functional consequences. Proc. Natl. Acad. Sci. USA 97: 3106-3111. 10716733
Kim, H., M.J. Rogers, J.E. Richmond, and S.L. McIntire. (2004). SNF-6 is an acetylcholine transporter interacting with the dystrophin complex in Caenorhabditis elegans. Nature 430: 891-896. 15318222
Kinjo, A., T. Koito, S. Kawaguchi, and K. Inoue. (2013). Evolutionary History of the GABA Transporter (GAT) Group Revealed by Marine Invertebrate GAT-1. PLoS One 8: e82410. 24312660
Kniazeff, J., C.J. Loland, N. Goldberg, M. Quick, S. Das, H.H. Sitte, J.A. Javitch, and U. Gether. (2005). Intramolecular cross-linking in a bacterial homolog of mammalian SLC6 neurotransmitter transporters suggests an evolutionary conserved role of transmembrane segments 7 and 8. Neuropharmacology 49: 715-723. 16129457
Koijam, A.S., A.C. Hijam, A.S. Singh, P. Jaiswal, K. Mukhopadhyay, U. Rajamma, and R. Haobam. (2020). Association of Dopamine Transporter Gene with Heroin Dependence in an Indian Subpopulation from Manipur. J Mol Neurosci. [Epub: Ahead of Print] 32557146
Kortagere S., Fontana AC., Rose DR. and Mortensen OV. (2013). Identification of an allosteric modulator of the serotonin transporter with novel mechanism of action. Neuropharmacology. 72:282-90. 23632081
Kowalczuk, S., A. Bröer, N. Tietze, J.M. Vanslambrouck, J.E. Rasko, and S. Bröer. (2008). A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB J. 22: 2880-2887. 18424768
Kragholm, B., T. Kvist, K.K. Madsen, L. Jørgensen, S.B. Vogensen, A. Schousboe, R.P. Clausen, A.A. Jensen, and H. Bräuner-Osborne. (2013). Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profile. Biochem Pharmacol 86: 521-528. 23792119
Kraut, J.A. and G. Sachs. (2005). Hartnup disorder: unraveling the mystery. Trends Pharmacol Sci 26: 53-55. 15681018
Krishnamurthy, H. and E. Gouaux. (2012). X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481: 469-474. 22230955
Krout, D., A.B. Pramod, R.A. Dahal, M.J. Tomlinson, B. Sharma, J.D. Foster, M.F. Zou, C. Boatang, A.H. Newman, J.R. Lever, R.A. Vaughan, and L.K. Henry. (2017). Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs. Biochem Pharmacol. [Epub: Ahead of Print] 28734777
Kurth, I., N. Yamaguchi, C. Andreu-Agullo, H.S. Tian, S. Sridhar, S. Takeda, F.C. Gonsalves, J.M. Loo, A. Barlas, K. Manova-Todorova, R. Busby, J.C. Bendell, J. Strauss, M. Fakih, A.J. McRee, A.E. Hendifar, L.S. Rosen, A. Cercek, R. Wasserman, M. Szarek, S.L. Spector, S. Raza, M.F. Tavazoie, and S.F. Tavazoie. (2021). Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Sci Adv 7: eabi7511. 34613776
Lambert, I.H. (2004). Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochem Res 29: 27-63. 14992263
Larsen, M.B., A.C. Fontana, L.G. Magalhães, V. Rodrigues, and O.V. Mortensen. (2011). A catecholamine transporter from the human parasite Schistosoma mansoni with low affinity for psychostimulants. Mol Biochem Parasitol 177: 35-41. 21251927
Le Guellec, B., F. Rousseau, M. Bied, and S. Supplisson. (2022). Flux coupling, not specificity, shapes the transport and phylogeny of SLC6 glycine transporters. Proc. Natl. Acad. Sci. USA 119: e2205874119. 36191186
Li, Y., Y. Zhao, X. Huang, X. Lin, Y. Guo, D. Wang, C. Li, and D. Wang. (2013). Serotonin control of thermotaxis memory behavior in nematode Caenorhabditis elegans. PLoS One 8: e77779. 24223727
Licht, J.A., S.P. Berry, M.A. Gutierrez, and R. Gaudet. (2024). They all rock: A systematic comparison of conformational movements in LeuT-fold transporters. bioRxiv. 38352416
Lin, Z. and G.R. Uhl. (2005). Proline mutations induce negative-dosage effects on uptake velocity of the dopamine transporter. J Neurochem 94: 276-287. 15953370
Liu, M., R.L. Russell, L. Beigelman, R.E. Handschumacher, and G. Pizzorno. (1999). β-alanine and α-fluoro-β-alanine concentrative transport in rat hepatocytes is mediated by GABA transporter GAT-2. Am. J. Physiol. 276: G206-210. 9886997
Luethi, D., J. Maier, D. Rudin, D. Szöllősi, T.J.F. Angenoorth, S. Stankovic, M. Schittmayer, I. Burger, J.W. Yang, K. Jaentsch, M. Holy, A.K. Das, M. Brameshuber, G.A. Camacho-Hernandez, A. Casiraghi, A.H. Newman, O. Kudlacek, R. Birner-Gruenberger, T. Stockner, G.J. Schütz, and H.H. Sitte. (2022). Phosphatidylinositol 4,5-bisphosphate (PIP) facilitates norepinephrine transporter dimerization and modulates substrate efflux. Commun Biol 5: 1259. 36396757
Luo, J., W. Wen, J. Chen, X. Zeng, P. Wang, and S. Xu. (2023). Differences in tissue distribution ability of evodiamine and dehydroevodiamine are due to the dihedral angle of the molecule stereo-structure. Front Pharmacol 14: 1109279. 37089948
Lygate, C.A., H.A. Lake, D.J. McAndrew, S. Neubauer, and S. Zervou. (2022). Influence of homoarginine on creatine accumulation and biosynthesis in the mouse. Front Nutr 9: 969702. 36017222
Lynagh T., Khamu TS. and Bryan-Lluka LJ. (2014). Extracellular loop 3 of the noradrenaline transporter contributes to substrate and inhibitor selectivity. Naunyn Schmiedebergs Arch Pharmacol. 387(1):95-107. 24081522
Malinauskaite L., Quick M., Reinhard L., Lyons JA., Yano H., Javitch JA. and Nissen P. (2014). A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters. Nat Struct Mol Biol. 21(11):1006-12. 25282149
Matskevitch, I., C.A. Wagner, C. Stegan, S. Bröer, B. Noll, T. Risler, H.M. Kwon, J.S. Handler, S. Waldegger, A.E. Busch, and F. Lang. (1999). Functional characterization of the betaine/γ-aminobutyric acid transporter BGT-1 expressed in Xenopus oocytes. J. Biol. Chem. 274: 16709-16716. 10358010
McCoy, K.E., X. Zhou, and P.D. Vize. (2008). Collectrin/tmem27 is expressed at high levels in all segments of the developing Xenopus pronephric nephron and in the Wolffian duct. Gene Expr Patterns 8: 271-274. 18226983
Meinild, A.-K., H.H. Sitte, and U. Gether. (2004). Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J. Biol. Chem. 279: 49671-49679. 15358780
Mercer, M.K., J.W. Revels, L.C. Blacklock, K.P. Banks, L.S. Johnson, D.H. Lewis, P.H. Kuo, S. Wilson, and S. Elojeimy. (2024). Practical Overview of I-Ioflupane Imaging in Parkinsonian Syndromes. Radiographics 44: e230133. 38236751
Merkle, P.S., K. Gotfryd, M.A. Cuendet, K.Z. Leth-Espensen, U. Gether, C.J. Loland, and K.D. Rand. (2018). Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT. Sci Adv 4: eaar6179. 29756037
Miszner, A., A. Peres, M. Castagna, S. Bettè, S. Giovannardi, F. Cherubino, and E. Bossi. (2007). Structural and functional basis of amino acid specificity in the invertebrate cotransporter KAAT1. J. Physiol. 581: 899-913. 17412764
Mostyn, S.N., K.A. Wilson, A. Schumann-Gillett, Z.J. Frangos, S. Shimmon, T. Rawling, R.M. Ryan, M.L. O''Mara, and R.J. Vandenberg. (2019). Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics. Elife 8:. 31621581
Motiwala, Z., N.G. Aduri, H. Shaye, G.W. Han, J.H. Lam, V. Katritch, V. Cherezov, and C. Gati. (2022). Structural basis of GABA reuptake inhibition. Nature 606: 820-826. 35676483
Müller, H.K., O. Wiborg, and J. Haase. (2006). Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2. J. Biol. Chem. 281: 28901-28909. 16870614
Nakanishi, T., Y. Fukuyama, M. Fujita, Y. Shirasaka, and I. Tamai. (2011). Carnitine Precursor γ-Butyrobetaine is a Novel Substrate of the Na+- and Cl--dependent GABA Transporter Gat2. Drug Metab Pharmacokinet 26: 632-636. 21997971
Nass, R., M.K. Hahn, T. Jessen, P.W. McDonald, L. Carvelli, and R.D. Blakely. (2005). A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. J Neurochem 94: 774-785. 15992384
Nayak, S.R., D. Joseph, G. Höfner, A. Dakua, A. Athreya, K.T. Wanner, B.I. Kanner, and A. Penmatsa. (2023). Cryo-EM structure of GABA transporter 1 reveals substrate recognition and transport mechanism. Nat Struct Mol Biol. [Epub: Ahead of Print] 37400654
Neubauer, H.A., C.G. Hansen, and O. Wiborg. (2006). Dissection of an allosteric mechanism on the serotonin transporter: a cross-species study. Mol Pharmacol 69: 1242-1250. 16434615
Nichols, A.L., Z. Blumenfeld, L. Luebbert, H.J. Knox, A.K. Muthusamy, J.S. Marvin, C.H. Kim, S.N. Grant, D.P. Walton, B.N. Cohen, R. Hammar, L. Looger, P. Artursson, D.A. Dougherty, and H.A. Lester. (2023). Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane. J. Neurosci. [Epub: Ahead of Print] 36868853
Noskov, S.Y., and B. Roux (2008). Control of ion selectivity in LeuT: two Na+ binding sites with two different mechanisms. J. Mol. Biol. 377: 804-818. 18280500
Nwosu, G., F. Mermer, C. Flamm, S. Poliquin, W. Shen, K. Rigsby, and J.Q. Kang. (2022). 4-Phenylbutyrate restored γ-aminobutyric acid uptake and reduced seizures in patient variant-bearing cell and mouse models. Brain Commun 4: fcac144. 35911425
Ortman, C.S. and J.M. Baltz. (2023). The cell volume-regulatory glycine transporter GLYT1 is activated following metallopeptidase-mediated detachment of the oocyte from the zona pellucida. Mol Reprod Dev. [Epub: Ahead of Print] 37811876
Paczkowski, F.A. and L.J. Bryan-Lluka. (2004). Role of proline residues in the expression and function of the human noradrenaline transporter. J Neurochem 88: 203-211. 14675164
Pak, K., S. Seo, M.J. Lee, H.J. Im, K. Kim, and I.J. Kim. (2022). Limited power of dopamine transporter mRNA mapping for predicting dopamine transporter availability. Synapse e22226. [Epub: Ahead of Print] 35104380
Palazzolo, L., C. Paravicini, T. Laurenzi, S. Adobati, S. Saporiti, U. Guerrini, E. Gianazza, C. Indiveri, C.M.H. Anderson, D.T. Thwaites, and I. Eberini. (2019). SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure. SLAS Discov 2472555219867317. [Epub: Ahead of Print] 31373846
Paudel, S., E. Kim, A. Zhu, S. Acharya, X. Min, S.H. Cheon, and K.M. Kim. (2021). Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake Inhibitors. Biomol Ther (Seoul). [Epub: Ahead of Print] 34053940
Paudel, S., S. Wang, E. Kim, D. Kundu, X. Min, C.Y. Shin, and K.M. Kim. (2021). Design, Synthesis, and Functional Evaluation of 1, 5-Disubstituted Tetrazoles as Monoamine Neurotransmitter Reuptake Inhibitors. Biomol Ther (Seoul). [Epub: Ahead of Print] 34789584
Pedersen AV., Andreassen TF. and Loland CJ. (2014). A conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporter. J Biol Chem. 289(50):35003-14. 25339174
Perez, C. and C. Ziegler. (2013). Mechanistic aspects of sodium-binding sites in LeuT-like fold symporters. Biol Chem 394: 641-648. 23362203
Pilkay, S., M. Nolasco, S. Nunes, A. Riffer, D. Femia, D. Halevy, T. Veerman, S. Heiland, N. Suwannimit, N. Trexler, and B. Gump. (2024). SLC6A4 gene variants moderate associations between childhood food insecurity and adolescent mental health. Brain Behav 14: e3426. 38361316
Piniella, D., E. Martínez-Blanco, D. Bartolomé-Martín, A.B. Sanz-Martos, and F. Zafra. (2021). Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter. Cell Mol Life Sci. [Epub: Ahead of Print] 34709416
Ponzoni, L., S. Zhang, M.H. Cheng, and I. Bahar. (2018). Shared dynamics of LeuT superfamily members and allosteric differentiation by structural irregularities and multimerization. Philos Trans R Soc Lond B Biol Sci 373:. 29735731
Preising, M.N., B. Görg, C. Friedburg, N. Qvartskhava, B.S. Budde, M. Bonus, M.R. Toliat, C. Pfleger, J. Altmüller, D. Herebian, M. Beyer, H.J. Zöllner, H.J. Wittsack, J. Schaper, D. Klee, U. Zechner, P. Nürnberg, J. Schipper, A. Schnitzler, H. Gohlke, B. Lorenz, D. Häussinger, and H.J. Bolz. (2019). Biallelic mutation of human encoding the taurine transporter TAUT is linked to early retinal degeneration. FASEB J. fj201900914RR. [Epub: Ahead of Print] 31345061
Qin, G., Y. Zhang, and S.K. Yao. (2020). Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance. World J Clin Cases 8: 1632-1641. 32432141
Quick, M. and B.R. Stevens. (2001). Amino acid transporter CAATCH1 is also an amino acid-gated cation channel. J. Biol. Chem. 276: 33413-33418. 11445577
Quick, M., H. Yano, N.R. Goldberg, L. Duan, T. Beuming, L. Shi, H. Weinstein, and J.A. Javitch. (2006). State-dependent conformations of the translocation pathway in the tyrosine transporter Tyt1, a novel neurotransmitter:sodium symporter from Fusobacterium nucleatum. J. Biol. Chem. 281: 26444-26454. 16798738
Ramamoorthy, S. and R.D. Blakely. (1999). Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285: 763-766. 10427004
Rappold, P.M., M. Cui, A.S. Chesser, J. Tibbett, J.C. Grima, L. Duan, N. Sen, J.A. Javitch, and K. Tieu. (2011). Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proc. Natl. Acad. Sci. USA 108: 20766-20771. 22143804
Rasmussen, S.G.F., F.I. Carroll, M.J. Maresch, A.D. Jensen, C.G. Tate, and U. Gether. (2001). Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter. J. Biol. Chem. 276: 4717-4723. 11062247
Reizer, J., A. Reizer, and M.H. Saier, Jr. (1994). A functional superfamily of sodium/solute symporters. Biochim. Biophys. Acta 1197: 133-166. 8031825
Rimoldi, S., E. Bossi, S. Harpaz, A.G. Cattaneo, G. Bernardini, M. Saroglia, and G. Terova. (2015). Intestinal B(0)AT1 (SLC6A19) and PEPT1 (SLC15A1) mRNA levels in European sea bass (Dicentrarchus labrax) reared in fresh water and fed fish and plant protein sources. J Nutr Sci 4: e21. 26097704
Rogala-Koziarska, K., &.#.3.2.1.;. Samluk, and K.A. Nałęcz. (2019). Amino acid transporter SLC6A14 depends on heat shock protein HSP90 in trafficking to the cell surface. Biochim. Biophys. Acta. Mol. Cell Res 1866: 1544-1555. 31326539
Rong, Z., F. Li, R. Zhang, S. Niu, X. Di, L. Ni, and C. Liu. (2023). Ant-Neointimal Formation Effects of SLC6A6 in Preventing Vascular Smooth Muscle Cell Proliferation and Migration via Wnt/β-Catenin Signaling. Int J Mol Sci 24:. 36769341
Rudnick G., Kramer R., Blakely RD., Murphy DL. and Verrey F. (2014). The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction. Pflugers Arch. 466(1):25-42. 24337881
Saenz, J., O. Yao, E. Khezerlou, M. Aggarwal, X. Zhou, D.J. Barker, E. DiCicco-Bloom, and P.Y. Pan. (2023). Cocaine-regulated trafficking of dopamine transporters in cultured neurons revealed by a pH sensitive reporter. iScience 26: 105782. 36594015
Sahai, M.A., C. Davidson, G. Khelashvili, V. Barrese, N. Dutta, H. Weinstein, and J. Opacka-Juffry. (2016). Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB. Prog Neuropsychopharmacol Biol Psychiatry. [Epub: Ahead of Print] 27890676
Santarelli, S., K.V. Wagner, C. Labermaier, A. Uribe, C. Dournes, G. Balsevich, J. Hartmann, M. Masana, F. Holsboer, A. Chen, M.B. Müller, and M.V. Schmidt. (2015). SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system. Stress 1-8. [Epub: Ahead of Print] 26585320
Savchenko, A., G. Targa, Z. Fesenko, D. Leo, R.R. Gainetdinov, and I. Sukhanov. (2023). Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience. Biomolecules 13:. 37238676
Schlessinger, A., E. Geier, H. Fan, J.J. Irwin, B.K. Shoichet, K.M. Giacomini, and A. Sali. (2011). Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET. Proc. Natl. Acad. Sci. USA 108: 15810-15815. 21885739
Schwartz, J.W., G. Novarino, D.W. Piston, and L.J. DeFelice. (2005). Substrate binding stoichiometry and kinetics of the norepinephrine transporter. J. Biol. Chem. 280: 19177-19184. 15757904
Scruggs, S.M., S. Disatian, and E.C. Orton. (2010). Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease. J Vet Cardiol 12: 163-169. 21036114
Sealover, N.R., B. Felts, C.P. Kuntz, R.E. Jarrard, G.H. Hockerman, E.L. Barker, and L.K. Henry. (2016). The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux. Biochem Pharmacol 120: 46-55. 27638414
Seyer, P., F. Vandermoere, E. Cassier, J. Bockaert, and P. Marin. (2016). Physical and functional interactions between the serotonin transporter and the neutral amino acid transporter ASCT2. Biochem. J. 473: 1953-1965. 27143784
Shekar, A., J.I. Aguilar, G. Galli, N.V. Cozzi, S.D. Brandt, A.E. Ruoho, M.H. Baumann, H.J.G. Matthies, and A. Galli. (2017). Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter. J Chem Neuroanat 83-84: 69-74. 28163218
Singer, D., S.M. Camargo, T. Ramadan, M. Schäfer, L. Mariotta, B. Herzog, K. Huggel, D. Wolfer, S. Werner, J.M. Penninger, and F. Verrey. (2012). Defective intestinal amino acid absorption in Ace2 null mice. Am. J. Physiol. Gastrointest Liver Physiol 303: G686-695. 22790597
Sloan, J. and S. Mager. (1999). Cloning and functional expression of a human Na+ and Cl--dependent neutral and cationic amino acid transporter B0+. J. Biol. Chem. 274: 23740-23745. 10446133
Snow, R.J. and R.M. Murphy. (2001). Creatine and the creatine transporter: a review. Mol. Cell Biochem 224: 169-181. 11693194
Sogawa, C., C. Mitsuhata, K. Kumagai-Morioka, N. Sogawa, K. Ohyama, K. Morita, K. Kozai, T. Dohi, and S. Kitayama. (2010). Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6. PLoS One 5: e11945. 20700532
Sohail, A., K. Jayaraman, S. Venkatesan, K. Gotfryd, M. Daerr, U. Gether, C.J. Loland, K.T. Wanner, M. Freissmuth, H.H. Sitte, W. Sandtner, and T. Stockner. (2016). The Environment Shapes the Inner Vestibule of LeuT. PLoS Comput Biol 12: e1005197. 27835643
Sorkina, T., M.H. Cheng, T.R. Bagalkot, C. Wallace, S.C. Watkins, I. Bahar, and A. Sorkin. (2021). Direct coupling of oligomerization and oligomerization-driven endocytosis of the dopamine transporter to its conformational mechanics and activity. J. Biol. Chem. 100430. [Epub: Ahead of Print] 33610553
Sorkina, T., S. Ma, M.B. Larsen, S.C. Watkins, and A. Sorkin. (2018). Small molecule induced oligomerization, clustering and clathrin-independent endocytosis of the dopamine transporter. Elife 7:. 29630493
Stolzenberg, S., Z. Li, M. Quick, L. Malinauskaite, P. Nissen, H. Weinstein, J.A. Javitch, and L. Shi. (2017). The Role of TM5 in Na2 Release and the Conformational Transition of Neurotransmitter:Sodium Symporters toward the Inward-Open State. J. Biol. Chem. [Epub: Ahead of Print] 28320858
Sucic, S. and L.J. Bryan-Lluka. (2007). Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants. Eur J Pharmacol 556: 27-35. 17141753
Supplisson, S. and M.J. Roux. (2002). Why glycine transporters have different stoichiometries. FEBS Lett. 529: 93-101. 12354619
Sweeney, C.G., B.P. Tremblay, T. Stockner, H.H. Sitte, and H.E. Melikian. (2016). Dopamine Transporter Amino- and Carboxy-Termini Synergistically Contribute to Substrate and Inhibitor Affinities. J. Biol. Chem. [Epub: Ahead of Print] 27986813
Szöllősi, D. and T. Stockner. (2021). Investigating the Mechanism of Sodium Binding to SERT Using Direct Simulations. Front Cell Neurosci 15: 673782. 34040506
Takanaga, H., B. Mackenzie, Y. Suzuki, and M.A. Hediger. (2005). Identification of mammalian proline transporter SIT1 (SLC6A20) with characteristics of classical system imino. J. Biol. Chem. 280: 8974-8984. 15632147
Tavoulari, S., A.N. Rizwan, L.R. Forrest, and G. Rudnick. (2011). Reconstructing a chloride-binding site in a bacterial neurotransmitter transporter homologue. J. Biol. Chem. 286: 2834-2842. 21115480
Tavoulari, S., E. Margheritis, A. Nagarajan, D.C. DeWitt, Y.W. Zhang, E. Rosado, S. Ravera, E. Rhoades, L.R. Forrest, and G. Rudnick. (2015). Two Na+ Sites Control Conformational Change in a Neurotransmitter Transporter Homolog. J. Biol. Chem. [Epub: Ahead of Print] 26582198
Thal, L.B., I.D. Tomlinson, M.A. Quinlan, O. Kovtun, R.D. Blakely, and S.J. Rosenthal. (2018). Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant. ACS Chem Neurosci. [Epub: Ahead of Print] 30153408
Tomi, M., A. Tajima, M. Tachikawa, and K. Hosoya. (2008). Function of taurine transporter (Slc6a6/TauT) as a GABA transporting protein and its relevance to GABA transport in rat retinal capillary endothelial cells. Biochim. Biophys. Acta. 1778: 2138-2142. 18501699
Trotschel C., Follmann M., Nettekoven JA., Mohrbach T., Forrest LR., Burkovski A., Marin K. and Kramer R. (2008). Methionine uptake in Corynebacterium glutamicum by MetQNI and by MetPS, a novel methionine and alanine importer of the NSS neurotransmitter transporter family. Biochemistry. 47(48):12698-709. 18991398
Uchiyama, T., T. Fujita, H.J. Gukasyan, K.J. Kim, Z. Borok, E.D. Crandall, and V.H. Lee. (2008). Functional characterization and cloning of amino acid transporter B(0,+) (ATB0,+) in primary cultured rat pneumocytes. J. Cell. Physiol. 214: 645-654. 17960566
Vandenberg, R.J., K. Shaddick, and P. Ju. (2007). Molecular Basis for Substrate Discrimination by Glycine Transporters. J. Biol. Chem. 282: 14447-14453. 17383967
Vidyadhara, D.J., M. Somayaji, N. Wade, B. Yücel, H. Zhao, N. Shashaank, J. Ribaudo, J. Gupta, T.T. Lam, D. Sames, L.E. Greene, D.L. Sulzer, and S.S. Chandra. (2023). Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson''s disease. Cell Rep 42: 112231. [Epub: Ahead of Print] 36920906
Vilca, S., C. Wahlestedt, S. Izenwasser, R.R. Gainetdinov, and M. Pardo. (2023). Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure. Biomolecules 13:. 37509143
Vincenti, S., M. Castagna, A. Peres, and V.F. Sacchi. (2000). Substrate selectivity and pH dependence of KAAT1 expressed in Xenopus laevis oocytes. J. Membr. Biol. 174: 213-224. 10758175
Walline, C.C., D.E. Nichols, F.I. Carroll, and E.L. Barker. (2008). Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition. J Pharmacol Exp Ther 325: 791-800. 18354055
Wang, H., A. Goehring, K.H. Wang, A. Penmatsa, R. Ressler, and E. Gouaux. (2013). Structural basis for action by diverse antidepressants on biogenic amine transporters. Nature 503: 141-145. 24121440
West, M., D. Park, J.R. Dodd, J. Kistler, and D.L. Christie. (2005). Purification and characterization of the creatine transporter expressed at high levels in HEK293 cells. Protein Expr Purif 41: 393-401. 15866727
Wunderlich, J. (2022). Updated List of Transport Proteins in. Front Cell Infect Microbiol 12: 926541. 35811673
Xu, L. and L.Y. Chen. (2021). Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions. Chem Biol Drug Des. [Epub: Ahead of Print] 33754484
Xue, W., F. Yang, P. Wang, G. Zheng, Y. Chen, X. Yao, and F. Zhu. (2018). What Contributes to Serotonin-Norepinephrine Reuptake Inhibitors'' Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics Simulation. ACS Chem Neurosci 9: 1128-1140. 29300091
Yamashita, A., Singh, S.K., Kawate, T., Jin, Y., and Gouaux, E. (2005). Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature 437: 215-223. 16041361
Yan, R., Y. Zhang, Y. Li, L. Xia, Y. Guo, and Q. Zhou. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367: 1444-1448. 32132184
Zaia, K.A. and R.J. Reimer. (2009). Synaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport. J. Biol. Chem. 284: 8439-8448. 19147495
Zapata A., B. Kivell, Y. Han, J.A. Javitch, E.A. Bolan, D. Kuraguntla, V. Jaligam, M. Oz, L.D. Jayanthi, D.J. Samuvel, S. Ramamoorthy, T.S. Shippenberg. (2007). Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J. Biol. Chem. 282: 35842-35854. 17923483
Zeppelin, T., L.K. Ladefoged, S. Sinning, X. Periole, and B. Schiøtt. (2018). A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition. PLoS Comput Biol 14: e1005907. 29329285
Zhang, Y.W. and G. Rudnick. (2006). The cytoplasmic substrate permeation pathway of serotonin transporter. J. Biol. Chem. 281: 36213-36220. 17008313
Zhang, Y.W., B.E. Turk, and G. Rudnick. (2016). Control of serotonin transporter phosphorylation by conformational state. Proc. Natl. Acad. Sci. USA 113: E2776-2783. 27140629
Zhang, Y.W., J. Gesmonde, S. Ramamoorthy, and G. Rudnick. (2007). Serotonin transporter phosphorylation by cGMP-dependent protein kinase is altered by a mutation associated with obsessive compulsive disorder. J. Neurosci. 27: 10878-10886. 17913921
Zhang, Y.W., S. Tavoulari, S. Sinning, A.A. Aleksandrova, L.R. Forrest, and G. Rudnick. (2018). Structural elements required for coupling ion and substrate transport in the neurotransmitter transporter homolog LeuT. Proc. Natl. Acad. Sci. USA 115: E8854-E8862. 30181291
Zhao, C. and S.Y. Noskov. (2013). The molecular mechanism of ion-dependent gating in secondary transporters. PLoS Comput Biol 9: e1003296. 24204233
Zhao, Y., D.S. Terry, L. Shi, M. Quick, H. Weinstein, S.C. Blanchard, and J.A. Javitch. (2011). Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue. Nature 474: 109-113. 21516104
Zhou, Y., E. Zomot, and B.I. Kanner. (2006). Identification of a lithium interaction site in the γ-aminobutyric acid (GABA) transporter GAT-1. J. Biol. Chem. 281: 22092-22099. 16757479
Zhou, Y., Z. Li, C. Chi, C. Li, M. Yang, and B. Liu. (2023). Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson''s Disease via Bioinformatics Analysis. Parkinsons Dis 2023: 6755569. 37089789
Zhu, A., J. Huang, F. Kong, J. Tan, J. Lei, Y. Yuan, and C. Yan. (2023). Molecular basis for substrate recognition and transport of human GABA transporter GAT1. Nat Struct Mol Biol. [Epub: Ahead of Print] 37400655
Zomot, E., A. Bendahan, M. Quick, Y. Zhao, J.A. Javitch, and B.I. Kanner (2007). Mechanism of chloride interaction with neurotransmitter:sodium symporters. Nature 449: 726-730. 17704762